جست‌وجوی استاد و پژوهشگر

• Cardiovascular Disease
• Atherosclerosis
• Vascular Biology
• +۳ مورد دیگر

Pei-Yu Chen is a Senior Research Scientist in the Department of Cardiovascular Medicine at Yale School of Medicine. She holds a PhD from the University of Maine (2009) and specializes in elucidating mechanisms underlying cardiovascular diseases, including atherosclerosis, aortic aneurysms, and vascular inflammation. Her work focuses on TGFβ signaling, endothelial-to-mesenchymal transition (EndMT), and the role of FGF and mTOR pathways in vascular pathologies. Recent efforts aim to develop safer drug delivery methods targeting these pathways. Research Interests: Chen's studies integrate molecular biology and translational approaches to understand how cellular signaling cascades drive vascular disease progression. Key areas include: TGFβ and FGF pathway cross-talk in endothelial dysfunction Mechanisms of smooth muscle cell phenotypic switching Role of mTOR in vascular inflammation and remodeling Preclinical models for atherosclerosis and aneurysm studies Publications Highlight: Her recent articles (2020-2023) emphasize TGFβ inhibition strategies, EndMT regulation, and mTOR pathway interventions. A 2023 study proposed novel therapeutic approaches targeting TGFβ signaling in cardiovascular diseases. Awards: No specific honors listed, though her research has been highlighted in Yale Medicine articles for innovative drug delivery concepts. Collaborations: Works closely with cardiovascular teams at Yale School of Medicine, focusing on preclinical drug development and vascular biology.

• Colorectal Surgery
• Oncology
• Surgical Outcomes Research
• +۳ مورد دیگر

Dr. Haddon Pantel is an Assistant Professor of Surgery (Colon and Rectal) at Yale School of Medicine. He specializes in treating benign, inflammatory, and cancerous diseases of the colon, rectum, and anus, including diverticulitis and inflammatory bowel disease. He completed his MD at the University of Vermont Larner College of Medicine, followed by general surgery residency and colon and rectal surgery fellowship at Lahey Clinic. Research Interests: His work focuses on surgical outcomes, colorectal cancer management, and healthcare cost analysis. Key topics include low anterior resection syndrome, mismatch repair deficient colon cancer, and anal cancer screening in HIV-positive men who have sex with men. Publications: Recent work explores surgical practice patterns, CT-based cancer staging, and pelvic floor therapy for post-surgical complications. Notable studies address cost-effectiveness of regionalized rectal cancer surgery and predictive factors for bowel dysfunction after proctectomy. Affiliations: Active in departments such as the Cancer Prevention and Control Center, Hepatic Arterial Infusion Program, and Oligometastatic Cancer Program. Board certified in General Surgery and Colon and Rectal Surgery. Education & Mentorship: Contributes to surgical education through residency training and program directorship studies. Advocates for early colorectal cancer screening, emphasizing colonoscopy as a preventive measure.

Bart Ghesquièreمشاهده پروفایل

استاد

• metabolomics
• mass spectrometry
• biochemistry
• +۶ مورد دیگر

Bart Ghesquière is a Full Professor at the Department of Cellular and Molecular Medicine, Faculty of Medicine, KU Leuven, and heads the Metabolomics Expertise Center at the VIB-KU Leuven Center for Cancer Biology. He leads the Laboratory of Applied Mass Spectrometry (LAMaS) and serves as head of the Proteomics Core Facility at KU Leuven. His leadership extends to multiple research initiatives including membership in the VIB-KU Leuven Center for Cancer Biology, LISCO (KU Leuven Institute for Single Cell Omics), and LKI (KU Leuven Cancer Institute. He also participates in institutional governance as a member of the Council of the Faculty of Medicine and the Council of the Department of Cellular and Molecular Medicine. Dr. Ghesquière's research focuses on metabolomics, mass spectrometry, biochemistry, and stable isotope tracing. His work centers on tracer metabolomics, which provides comprehensive insights into metabolic pathways ('Google Maps of Biochemistry'), revealing both the activity and interconnectivity of biochemical pathways across diverse biological contexts. His laboratory develops novel mass spectrometry-based technologies while applying them to study metabolic disorders and syndromes, with particular emphasis on congenital disorders of glycosylation, mitochondrial disorders, and organ metabolism during transplantation procedures. His scientific contributions include the development of innovative tools like TraVis Pies for stable isotope metabolomics interpretation and significant discoveries in metabolic pathways related to glycosylation disorders, kidney perfusion, and cellular metabolism under stress conditions. His work has been published in high-impact journals including Nature, Cell Reports, and American Journal of Human Genetics. Orloff Science award (received during his work at NIH) Dr. Ghesquière currently leads a team of 11 researchers including a project manager, expert technicians, senior postdoctoral scientists, data analysts, and PhD students. He serves as promotor for two PhD students and co-promotor for three others. His research is supported by multiple ongoing projects including studies on de novo serine biosynthesis in obesity-induced cardiomyocyte dysfunction, short chain fatty acids in hepatic lipid metabolism, and nuclear metabolism in cancer cells under hypoxia. His laboratory provides metabolomics services to research groups while developing novel technologies and biological applications. The Metabolomics Expertise Center under Dr. Ghesquière's leadership functions as both a service facility for metabolomics-oriented research groups and an innovative research hub developing cutting-edge technologies in tracer metabolomics. His team has developed specialized software like MAIMS for metabolic tracer analysis and continues to advance hardware and methodology in the field. The laboratory maintains strong collaborations across multiple disciplines, particularly in cancer biology, transplantation medicine, and rare metabolic disorders.

Ron Gansevoortمشاهده پروفایل

استاد

• Chronic Kidney Disease
• Polycystic Kidney Disease (ADPKD)
• Albuminuria
• +۳ مورد دیگر

Prof. Ron Gansevoort is a Professor of Medicine at the University of Groningen's Faculty of Medical Sciences, affiliated with the UMCG. He leads research in nephrology, focusing on chronic kidney disease (CKD), autosomal dominant polycystic kidney disease (ADPKD), and cardiovascular comorbidities. His work emphasizes epidemiology, prevention strategies, and biomarker development (e.g., albuminuria). Roles & Affiliations Principal Investigator of the Renal Lifecycle trial and Check@Home consortium Co-leader of the DIPAK and EuroCYST consortia Member of steering committees for PREVEND, FIGARO, and FIDELIO studies Director of the Groningen Kidney Center (GKC) Research Interests Mechanisms of CKD progression and cardiovascular risk Novel therapeutic targets in ADPKD (e.g., SGLT2 inhibitors) Population-based studies like the Prevention of Renal and Vascular End-stage Disease (PREVEND) Clinical trials evaluating tolvaptan and other treatments Awards 2018: Fellow of the American Society of Nephrology 2011: United States Kidney Foundation Distinguished International Medal 2019: Top 5 best publication in Journal of the American Society of Nephrology Grants & Leadership Principal Investigator for multiple NIH/EU-funded projects Supervised 31 PhD/Master's students Editorial roles in leading nephrology journals Labs & Collaborations Groningen Kidney Center (GKC): Focus on translational nephrology research Cardiovascular Centre (CVC): Cross-disciplinary heart-kidney interaction studies International networks: DIPAK, EuroCYST, and the CONNECT Action

C. Munro Cullumمشاهده پروفایل

استاد

• Clinical Neuropsychology
• Concussion and Traumatic Brain Injury
• Alzheimer’s Disease
• +۳ مورد دیگر

C. Munro Cullum, Ph.D., ABPP-CN is a tenured Professor at the University of Texas Southwestern Medical Center , where he holds joint appointments in Psychiatry, Neurology, and Neurological Surgery . As Vice Chair and Chief of Psychology in Psychiatry and Senior Neuropsychologist at the Peter O’Donnell Brain Institute, he bridges clinical care, research, and administration. His career spans over three decades since his 1985 Ph.D. from UT Austin, followed by training at UC San Diego and the San Diego VA. Education: Ph.D. in Clinical Psychology, University of Texas at Austin Research Interests focus on cognitive consequences of brain injury , neurodegenerative disease progression , and telehealth innovations . Key areas include: Concussion effects in athletes (NFL, youth sports) Alzheimer’s Disease risk factors and differential diagnosis Telemedicine applications for neuropsychological assessment Neuroimaging correlates of cognitive decline Publication Trends reveal interdisciplinary work spanning neurology, sports medicine, and genetics , with recent studies on genomic risk loci for Alzheimer’s , AI-driven cognitive assessment , and long-term TBI outcomes . Scientific Leadership includes: Founding board-certified clinical neuropsychologist at UT Southwestern Scientific Director of the Texas Alzheimer’s Research and Care Consortium Former leadership roles in major neuropsychology societies Awards reflect his status as a Fellow in the National Academy of Neuropsychology , Society for Clinical Neuropsychology (APA Division 40) , and Sports Neuropsychology Society . His work on concussion recovery and dementia prevention has shaped clinical guidelines.

Sebastian Albinssonمشاهده پروفایل

مدرس ارشد

• Vascular Physiology
• Smooth Muscle Biology
• MicroRNA Research
• +۳ مورد دیگر

Sebastian Albinsson is a Senior Lecturer and Molecular Vascular Physiology Researcher at Lund University's Faculty of Medicine. He holds roles as Research Team Manager, Course Director, and Principal Investigator within the EXODIAB: Excellence of Diabetes Research in Sweden initiative. His work contributes to UN Sustainable Development Goals focused on health and well-being. Research Interests: Albinsson specializes in vascular physiology, smooth muscle biology, and the role of microRNAs in cardiovascular disease. His research explores hypertension mechanisms, aneurysm development, and molecular pathways regulating vascular smooth muscle function. Key focuses include YAP/TAZ signaling, actin cytoskeleton dynamics, and transcription factor-driven processes in vascular pathology. Recent Article Trends: Recent work emphasizes genome sequencing in heart failure, YAP/TAZ regulation in vascular mechanotransduction, and microRNA-driven lipid accumulation. These studies highlight translational applications in precision medicine and disease prevention. Grants & Projects: Exploring the relationship between metabolic vascular disease, smooth muscle mechanosensing and vascular ageing (2025–2026) Kan blodkärlens sträcksenor skydda mot aneurysm? (2024–2026) Advising: Supervised 8 research works, focusing on vascular biology and molecular mechanisms. Labs/Teams: Active in EXODIAB and the Molecular Vascular Physiology group, collaborating internationally on cardiovascular and diabetes research.

Matthew Bozigarمشاهده پروفایل

استادیار

• Environmental Epidemiology
• Public Health
• Air Pollution Exposure
• +۵ مورد دیگر

Matthew Bozigar, PhD, is an Assistant Professor in the Department of Epidemiology at Oregon State University's School of Nutrition and Public Health. His research focuses on environmental exposures such as noise, air pollution, and radon, examining their impacts on asthma, cancer, and cardiometabolic diseases through a geographical lens. He emphasizes 'place' as a critical factor in population health, integrating geospatial data with electronic health records. Dr. Bozigar has received a $50K New Investigator Grant from the Medical Research Foundation (2025-26) for his project investigating radon's role in non-pulmonary cancers. His work has been featured in high-impact studies linking aircraft noise to hypertension, obesity, and sleep disruption, as well as radon exposure to childhood leukemia risk across 727 U.S. counties. Publications highlight his expertise in cohort studies, Bayesian modeling, and environmental justice. He actively engages in community outreach, including collaborations with school nurses to improve HPV vaccination rates and developing algorithms to identify asthma disparities using geographic identifiers. Dr. Bozigar's research bridges environmental determinants with clinical outcomes, emphasizing equity and policy relevance.

• Vascular Biology
• Endothelial Cell Biology
• Macrophage Biology
• +۱۳ مورد دیگر

Yajaira Suarez is the Anthony N. Brady Professor of Comparative Medicine and Pathology at Yale School of Medicine, where she also serves as Deputy Chair of the Department of Comparative Medicine. She holds secondary appointments in Pathology and is affiliated with multiple interdisciplinary research centers, including the Yale Cancer Center, Vascular Biology and Therapeutics Program, Yale Center for Molecular and Systems Metabolism (YMSM), and the Center for RNA Science and Medicine. PhD, Universidad Autónoma de Madrid (2001) BS, Universidad Autónoma de Madrid (1995) Postdoctoral Training, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad Autónoma de Madrid Postdoctoral Training, Yale University School of Medicine Her research focuses on endothelial cell and macrophage biology, particularly the interplay between angiogenesis, inflammation, and metabolism in diseases such as atherosclerosis, cancer, and metabolic disorders. She investigates the role of non-coding RNAs, metabolic rewiring, immunometabolism, and cholesterol regulation in vascular and inflammatory pathologies. Her recent publications reveal a strong trend in endothelial and macrophage metabolism, lipid signaling, and non-coding RNA regulation in vascular and liver diseases. Key themes include the protective role of endothelial triglyceride metabolism, metabolic reprogramming in angiogenesis, and miR-33’s role in liver and neuronal regulation. These works span top journals such as Nature Communications , Journal of Clinical Investigation , and Circulation . Notable scientific awards include: 2025 Recipient of the Judah Folkman Award in Vascular Biology Elected member of the Connecticut Academy of Science and Engineering (2022) Werner Risau New Investigator Award in Vascular Biology Kingsley Award in Medical Research (Yale) CNIC P3+3 Postdoctoral Fellowship (Spain) Dr. Suarez has secured significant research funding and leads a vibrant laboratory collaborating with prominent scientists such as Carlos Fernandez-Hernando, Jordan Pober, and Bill Sessa. She mentors numerous postdoctoral fellows and graduate students and is actively involved in training programs like the Yale Combined Program in the Biological and Biomedical Sciences (BBS). Her work bridges basic science with translational applications in cardiometabolic and vascular diseases. She leads research initiatives within the Vascular Biology and Therapeutics Program and collaborates extensively through centers such as the Diabetes Research Center and the Cancer Signaling Networks. Her lab utilizes genetically modified mouse models and molecular techniques to dissect regulatory mechanisms in vascular and metabolic diseases.

• Neurology
• Autonomic Nervous System
• Stroke
• +۷ مورد دیگر

Dr. med. univ. Elisabeth Daniela Olbert is a senior physician in the Department of Neurology at Tulln University Hospital, affiliated with the Karl Landsteiner Private University of Health Sciences. She actively contributes to clinical research through the Forschungsimpulse program, focusing on autonomic nervous system dysfunction in stroke, multiple sclerosis, and other cerebrovascular conditions. She leads multiple prospective studies and collaborates with Prim. Assoc. Prof. PD Dr. Walter Struhal. Medical University of Vienna – Medical Studies Residency in Neurology – Zurich and Austria Technical College for Mechatronics – Early Education Elisabeth Olbert's research centers on the autonomic nervous system's role in neurological diseases, particularly its impact on stroke, cerebral autoregulation, and cognitive function in multiple sclerosis. She utilizes real-world clinical data and leads prospective studies on vascular interventions. Her work bridges clinical neurology with data science, leveraging her background in mechatronics for signal processing and data analysis. Her recent publications reflect a strong focus on autonomic dysregulation following acute neurological events like stroke and hemorrhage, as well as rare neuroinflammatory conditions such as MOG antibody disease and NMOSD. She also contributes to broader topics like chronic fatigue syndrome and gender-specific stroke management, demonstrating a comprehensive approach to clinical neurology and patient-centered research. While no formal scientific awards are listed in the provided texts, her leadership as principal investigator on multiple funded research projects highlights her active and recognized role in the academic community. Dr. Olbert supervises or advises no named students in the available data. However, she is deeply involved in research projects such as AFFRICATE and studies on autonomic dysfunction in MS, which likely involve collaboration with junior researchers and clinicians. Her work is supported by institutional research funding from Forschungsimpulse. She is a key contributor to the autonomic neuroscience research group at Tulln University Hospital, participating in the European Programme of Clinical Autonomic Neuroscience (EPOCAN). Her work involves multidisciplinary collaboration with neurologists, data scientists, and clinical researchers across multiple Austrian hospitals in multicenter studies.

Tom Hobmanمشاهده پروفایل

استاد

• Virology
• RNA Virus-Host Interactions
• Antiviral Therapeutics
• +۱۵ مورد دیگر

Tom Hobman is a Professor in the Department of Cell Biology at the Faculty of Medicine & Dentistry, University of Alberta. His research focuses on RNA virus-host interactions and the regulation of RNA interference pathways in diseases such as breast cancer. He leads an active laboratory investigating viruses including SARS-CoV-2, Zika, HIV, and West Nile virus, with a focus on identifying host pathways for broad-spectrum antiviral therapies. Research Interests: RNA virus-host interactions, particularly with SARS-CoV-2, Zika, Dengue, and HIV Host cell pathways exploited by multiple RNA viruses Development of broad-spectrum antivirals targeting host factors Regulation of Argonaute proteins and miRNA pathways in breast cancer Peroxisome biology in viral infection and immune signaling Interferon response modulation by viral proteins The recent publications show a strong trend in virology and host-pathogen interactions, particularly focusing on SARS-CoV-2 mechanisms of immune evasion, Zika virus persistence in fetal and reproductive tissues, and the role of cellular organelles like peroxisomes in antiviral signaling. The work spans molecular virology, cell biology, and therapeutic development, with increasing emphasis on host-directed antiviral strategies. Scientific Awards: Canada Research Chair in RNA Viruses and Host Interactions (2010–2018) Fellow of the Canadian Academy of Health Sciences (2021) Grants and Advising: Dr. Hobman’s research is supported by the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council (NSERC), and Tonix Pharmaceuticals. He actively mentors graduate students and postdoctoral fellows, including Alberto Felix-Lopez, Mohamed Elaish, and Joaquín López-Orozco, fostering a collaborative environment in virology and molecular cell biology. Laboratory and Team: The Hobman Lab includes postdoctoral fellows, research associates, graduate students, and technicians working on various aspects of viral pathogenesis and RNA biology. Key members include Dr. Mohamed Elaish, Dr. Joaquín López-Orozco, Dr. Zaikun Xu, and technicians Nawell Fayad, Valeria Mancinelli, and Eileen Reklow. The lab employs super-resolution imaging, molecular virology, and functional genomics to study viral mechanisms.

Stijn P. De Langheمشاهده پروفایل

استاد

• Lung Regeneration
• Lung Development
• Pulmonary Fibrosis
• +۱۲ مورد دیگر

Stijn P. De Langhe, Ph.D., is a Professor at Mayo Clinic in Rochester, Minnesota, with appointments in the Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, and the Department of Biochemistry and Molecular Biology. His research is centered on lung regeneration, focusing on the molecular mechanisms of lung development and their role in diseases such as pulmonary fibrosis, COPD, asthma, and ARDS. Dr. De Langhe’s research interests lie in understanding lung stem cell niche interactions, particularly the bidirectional signaling between epithelial and mesenchymal cells. His work emphasizes how developmental pathways like FGF10 and Hippo signaling are reactivated during injury and repair, and how their dysregulation contributes to fibrotic lung diseases. He explores processes including cell quiescence, proliferation, differentiation, migration, and survival in the context of lung regeneration. The trends in his recent publications highlight a consistent focus on FGF10 signaling, epithelial-mesenchymal crosstalk, Hippo pathway regulation, and niche-mediated repair. His studies utilize mouse models and advanced techniques such as fluorescence in situ hybridization to investigate mechanisms of cell competition, bronchiolization, and alveolar epithelial regeneration in pulmonary fibrosis. Chair, 2nd Epithelial Mesenchymal Interactions in Lung Development and Fibrosis Conference, Fusion Conferences, 2022 Chair, Epithelial Mesenchymal Interactions in Lung Development and Fibrosis Conference, Fusion Conferences, 2019 Dr. De Langhe has been a principal investigator on multiple NIH-funded research projects, including ongoing studies on cell competition in pulmonary fibrosis and ARDS, epithelial stem cell Hippo signaling, and FGF10-mediated epithelial-mesenchymal interactions. He has collaborated extensively with researchers across institutions and disciplines. His lab serves as a hub for investigating lung developmental biology and its implications for regenerative medicine. He has mentored numerous trainees and contributes to major scientific conferences in his field.

• Actin Dynamics
• Cell Migration
• Cytoskeleton Regulation
• +۵ مورد دیگر

Prof. Dr. Klemens Rottner is a leading cell biologist at the Institute for Zoology (Technische Universität Braunschweig) and head of the Molecular Cell Biology research group at the Helmholtz Centre for Infection Research (HZI) . With a career spanning institutions like the University of Bonn and the former GBF Braunschweig, he specializes in actin dynamics, cell migration, and host-pathogen interactions. His work bridges fundamental cytoskeletal mechanisms with applications in cancer, neurodegeneration, and bacterial infections.

• Polycystic Kidney Diseases
• Chronic Renal Insufficiency
• Baroreflex
• +۷ مورد دیگر

Cara Hildreth is an Associate Professor and Associate Dean Curriculum and Learning at Macquarie Medical School, Macquarie University. Her research focuses on the interplay between kidney disease and cardiovascular dysfunction, particularly in polycystic kidney disease and chronic renal insufficiency. Research Interests: Polycystic Kidney Diseases, Chronic Renal Insufficiency, Baroreflex, Heart Rate, Hypertension, Blood Pressure, Rodentia, Cardiovascular Physiology, Neurophysiology. Key Projects: Understanding brain-kidney interactions in hypertension, vascular calcification in chronic kidney disease, and stress-induced brain rewiring in polycystic kidney disease. Recent Publications (2024–2025): Articles on optogenetic blood pressure regulation, sex-based cardiovascular risk in CKD, reno-renal reflex impairments, and therapeutic effects of kudzu/chaga extracts in diabetes models. She collaborates with researchers like J.K. Phillips, A. Lee, and R. Chung. Her work involves both clinical and basic science approaches, including rodent models and neurophysiological studies.

Judith Bruchfeldمشاهده پروفایل

دانشیار

• Infectious Diseases
• Tuberculosis
• Multidrug-Resistant Tuberculosis
• +۱۱ مورد دیگر

Judith Bruchfeld is a docent in Infectious Diseases and Chief Physician at Karolinska Institutet’s Department of Medicine, Solna, and Karolinska University Hospital. She leads a clinical research group focused on tuberculosis and long-term effects of COVID-19, and has established a multidisciplinary long-COVID clinic to assess patients with persistent symptoms. Her research interests include: Multidrug-resistant tuberculosis (MDR-TB) treatment optimization Pharmacokinetics and drug exposure in TB Long-term sequelae of SARS-CoV-2 infection (PASC) Postural orthostatic tachycardia syndrome (POTS) Microvascular and cardiac dysfunction post-COVID Global TB control and diagnostics Immune responses in TB and post-viral syndromes Her recent publications highlight a strong focus on long-COVID, particularly cardiovascular and autonomic complications, using biomarkers, imaging, and interventional therapies. She also continues to publish extensively on TB, especially drug resistance, dosing, and treatment outcomes in global cohorts. Her work combines clinical research, epidemiology, and translational science. She has contributed to WHO guidelines on latent TB management and is involved in international collaborations on TB and long-COVID. She supervises researchers and leads studies on diagnostic pathways, stigma, and quality of life in TB and post-COVID patients. Her research is supported by grants, including a SEK 19 million award for long-COVID research. She is active in public outreach, media engagement, and advocacy for gender equality in medicine.

Brian Buttonمشاهده پروفایل

استاد

• Respiratory Medicine
• Biochemistry
• Biophysics
• +۴ مورد دیگر

Brian Button is a Professor in the Department of Biochemistry & Biophysics at the UNC School of Medicine, with joint appointments in UNC Medicine and Biomedical Engineering. He holds a PhD from the University of Texas Medical Branch and focuses on the biophysical properties of mucus, the periciliary layer (PCL), and mucociliary clearance mechanisms. His research spans respiratory diseases like cystic fibrosis and chronic bronchitis, integrating experimental and computational approaches. Research Interests: Mucus hydration and hyperconcentration in chronic lung diseases Biophysical interactions in SARS-CoV-2 infection Mechanosensitive ATP release in airway homeostasis Mucin dynamics and their role in pulmonary disorders Therapeutic strategies for mucociliary dysfunction Recent Publications: His work explores mucus concentration-dependent pathophysiology, SARS-CoV-2 host factors, and mathematical models of airway regulation. Articles emphasize mucin hyperconcentration, mucociliary clearance, and climate impacts on respiratory health. Collaborations: He works with teams at the Marsico Lung Institute and UNC Cystic Fibrosis Center, using techniques like optical coherence tomography and CRISPR screening.